Apellis Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.65 | $157.41 M | -2.5 | 51 | $0 |
AKRO
Akero Therapeutics, Inc. |
$25.11 | $1.59 B | -7.1 | 60 | $0 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.60 | $120.37 M | -1.65 | 384 | $380.79 M |
BPMC
Blueprint Medicines Corporation |
$110.01 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.53 | $1.12 B | -5.11 | 174 | $0 |
IMVT
Immunovant, Inc. |
$23.87 | $3.68 B | -13.39 | 207 | $0 |
INZY
Inozyme Pharma, Inc. |
$1.36 | $286.39 M | -3.43 | 59 | $0 |
MDGL
Madrigal Pharmaceuticals, Inc. |
$293.36 | $5.21 B | -10.55 | 376 | $0 |
MREO
Mereo BioPharma Group plc |
$2.86 | $479.72 M | -22.8 | 33 | $10.00 M |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
RXDX
Prometheus Biosciences, Inc. |
$199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
TERN
Terns Pharmaceuticals, Inc. |
$4.44 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.52 | $169.62 M | -1.51 | 127 | $0 |